Brooks O'Neil
Stock Analyst at Lake Street
(0.48)
# 4,071
Out of 4,455 analysts
321
Total ratings
39.9%
Success rate
-2.6%
Average return
Main Sectors:
Stocks Rated by Brooks O'Neil
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| MDXG MiMedx Group | Maintained: Buy | $12 → $5 | $3.93 | +27.23% | 9 | Apr 30, 2026 | |
| LFMD LifeMD | Maintained: Buy | $12 → $18 | $4.13 | +335.84% | 9 | Jul 10, 2025 | |
| TNDM Tandem Diabetes Care | Maintained: Buy | $75 | $16.24 | n/a | 37 | May 20, 2025 | |
| PIII P3 Health Partners | Maintained: Buy | $20 | $11.38 | n/a | 13 | May 16, 2025 | |
| ELMD Electromed | Maintained: Buy | $36 | $41.46 | n/a | 9 | May 14, 2025 | |
| RCEL AVITA Medical | Maintained: Buy | $14 | $3.97 | n/a | 29 | May 9, 2025 | |
| ORGO Organogenesis Holdings | Maintained: Buy | $5 | $2.43 | n/a | 5 | May 9, 2025 | |
| ASTH Astrana Health | Reiterated: Buy | $70 | $44.51 | n/a | 14 | May 9, 2025 | |
| INFU InfuSystem Holdings | Reiterated: Buy | $13 | $10.05 | n/a | 15 | May 8, 2025 | |
| LFVN LifeVantage | Maintained: Buy | $30 | $6.62 | n/a | 6 | May 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $30 | $16.82 | n/a | 3 | May 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $15 | $11.63 | n/a | 14 | May 6, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $18 | $9.30 | n/a | 36 | May 2, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $6 | $0.2646 | n/a | 24 | May 1, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $30 → $10 | $0.015 | n/a | 16 | Jan 13, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $55 | $42.07 | n/a | 23 | Nov 14, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $75 | $95.66 | n/a | 12 | May 3, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $30 → $15 | $8.52 | n/a | 16 | Mar 8, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $20 → $4 | $0.000001 | n/a | 3 | Feb 9, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $3 → $25 | $3.30 | n/a | 3 | Mar 1, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $8 → $200 | $0.0001 | n/a | 3 | Aug 12, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $35 → $45 | $21.82 | n/a | 10 | Jul 28, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $11 | $4.94 | n/a | 1 | Apr 8, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $20 | $0.7086 | n/a | 1 | Apr 9, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $0.34 | $8.61 | n/a | 1 | Sep 15, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $14 | $6.55 | n/a | 1 | Aug 17, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $15 | $35.70 | n/a | 2 | Jul 28, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $22 → $27 | $23.61 | n/a | 2 | May 1, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $7 | $4.99 | n/a | 1 | May 20, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgraded: Buy | $12 | $13.22 | n/a | 1 | Nov 2, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $35 → $40 | $68.78 | n/a | 2 | Dec 12, 2013 |
MiMedx Group
Apr 30, 2026
Maintained: Buy
Price Target: $12 → $5
Current: $3.93
Upside: +27.23%
LifeMD
Jul 10, 2025
Maintained: Buy
Price Target: $12 → $18
Current: $4.13
Upside: +335.84%
Tandem Diabetes Care
May 20, 2025
Maintained: Buy
Price Target: $75
Current: $16.24
Upside: n/a
P3 Health Partners
May 16, 2025
Maintained: Buy
Price Target: $20
Current: $11.38
Upside: n/a
Electromed
May 14, 2025
Maintained: Buy
Price Target: $36
Current: $41.46
Upside: n/a
AVITA Medical
May 9, 2025
Maintained: Buy
Price Target: $14
Current: $3.97
Upside: n/a
Organogenesis Holdings
May 9, 2025
Maintained: Buy
Price Target: $5
Current: $2.43
Upside: n/a
Astrana Health
May 9, 2025
Reiterated: Buy
Price Target: $70
Current: $44.51
Upside: n/a
InfuSystem Holdings
May 8, 2025
Reiterated: Buy
Price Target: $13
Current: $10.05
Upside: n/a
LifeVantage
May 7, 2025
Maintained: Buy
Price Target: $30
Current: $6.62
Upside: n/a
May 7, 2025
Maintained: Buy
Price Target: $30
Current: $16.82
Upside: n/a
May 6, 2025
Maintained: Buy
Price Target: $15
Current: $11.63
Upside: n/a
May 2, 2025
Reiterated: Buy
Price Target: $18
Current: $9.30
Upside: n/a
May 1, 2025
Maintained: Buy
Price Target: $6
Current: $0.2646
Upside: n/a
Jan 13, 2025
Rated: Buy
Price Target: $30 → $10
Current: $0.015
Upside: n/a
Nov 14, 2024
Rated: Buy
Price Target: $55
Current: $42.07
Upside: n/a
May 3, 2024
Reiterated: Buy
Price Target: $75
Current: $95.66
Upside: n/a
Mar 8, 2024
Rated: Buy
Price Target: $30 → $15
Current: $8.52
Upside: n/a
Feb 9, 2024
Maintained: Buy
Price Target: $20 → $4
Current: $0.000001
Upside: n/a
Mar 1, 2023
Maintained: Buy
Price Target: $3 → $25
Current: $3.30
Upside: n/a
Aug 12, 2022
Maintained: Buy
Price Target: $8 → $200
Current: $0.0001
Upside: n/a
Jul 28, 2022
Maintained: Buy
Price Target: $35 → $45
Current: $21.82
Upside: n/a
Apr 8, 2022
Initiated Coverage: Buy
Price Target: $11
Current: $4.94
Upside: n/a
Apr 9, 2021
Initiated Coverage: Buy
Price Target: $20
Current: $0.7086
Upside: n/a
Sep 15, 2020
Initiated Coverage: Buy
Price Target: $0.34
Current: $8.61
Upside: n/a
Aug 17, 2020
Reiterated: Buy
Price Target: $14
Current: $6.55
Upside: n/a
Jul 28, 2020
Maintained: Buy
Price Target: $15
Current: $35.70
Upside: n/a
May 1, 2020
Maintained: Buy
Price Target: $22 → $27
Current: $23.61
Upside: n/a
May 20, 2019
Initiated Coverage: Buy
Price Target: $7
Current: $4.99
Upside: n/a
Nov 2, 2018
Upgraded: Buy
Price Target: $12
Current: $13.22
Upside: n/a
Dec 12, 2013
Reiterated: Buy
Price Target: $35 → $40
Current: $68.78
Upside: n/a